So we started her on intravenous fluids and tobramycin, a potent antibiotic with potent side effects.

Another observation that the researchers made was that this biofilm is more susceptible to the antibiotic tobramycin.

Later we learned she had already received a dose in the E.R. — worrisome because tobramycin’s risk of harming the kidneys increases with accumulated doses.